GAO-17-564, INVESTIGATIONAL NEW DRUGS:: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify Ho
Single-Patient Expanded Access: An Infographic | Expanded Access Navigator
WEP Clinical on X: "Find out more about the FDA Expanded Access Programs https://t.co/e0Hz6g7zL2 https://t.co/0MioyEACpr" / X
Expanded Access to Investigational Drugs
Simplifying Paperwork and Increasing Patient Access to Oncology Compassionate Use Therapeutics - Medical Documentation Software, Clinical Documentation Improvement, CDI Clinical Documentation Improvement, CDI Program, Insight
FDA program helps patients access experimental treatments
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians | WCG
Expanded Access Application Quick Guidance for Drugs & Biologics
Exploring the Landscape for Compassionate Use | Clinigen
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect
Industry Perspective: Expanded Access Programs - ppt download
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians | WCG
Initiating Early Access Programs: 5 Things to Consider :: executive insight | healthcare consultants
Umbilical Cord MSCs Sales 2.0: Using the Expanded Access Program? - Regenexx
Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try” - ScienceDirect
Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO
FDA Expanded Access Program | OSF HealthCare
Regulatory Explainer: FDA's Expanded Access (Compassionate Use) Program | RAPS
Expanded Use of Investigational Drugs and Devices
Right to Try, expanded access use, Project Facilitate, and clinical trial reform - Annals of Oncology
Expanded Access to Unapproved Drugs, Biologics, or Devices | Human Research Protection Office (HRPO) | University of Pittsburgh
Expanded Access Software — MedaSystems Collaborative Software for Access to Investigational Medicine
U.S. Food and Drug Administration - Expanded Access is a potential pathway for patients with immediately life-threatening conditions to gain access to an investigational medical product. Here's how the process works: https://go.usa.gov/xmHwh
